Hong Kong stock market anomaly | Rongchang Biology (09995.HK) rises more than 3%, self-developed RC148 achieves dual-path breakthrough, institutions optimistic about future clinical potential.

According to the Securities Times app, Rongchang Bio (09995.HK) has risen more than 3%, as of the time of publication, it has risen by 3.41%, to 78.8 Hong Kong dollars, with a turnover of 98.3812 million Hong Kong dollars.